Guide to Creatinine with GFR Estimated (eGFR)
Summary
Creatinine with GFR Estimated (eGFR) is a blood test that checks how well your kidneys are functioning by measuring your creatinine level and estimating filtration ability based on your age, sex, and other personal characteristics.
Why It Matters
Creatinine is a waste product from muscle metabolism. It's produced at a relatively constant rate through normal muscle use and is eliminated at a steady rate by the kidneys. When kidney function declines, creatinine accumulates in the bloodstream.
It's important to understand that creatinine itself is a direct laboratory measurement from your blood sample, while eGFR is not directly measured but calculated using an equation. The eGFR calculation uses your creatinine levels along with factors like age, sex, and body size to estimate how much blood passes through the kidneys' filtering units (glomeruli) per minute. This provides a personalized assessment of kidney function that is more accurate than creatinine alone, as creatinine can vary based on muscle mass and other factors.
These markers matter because kidney disease often progresses silently until significant damage has occurred. Regular monitoring can detect changes in kidney function before symptoms appear, allowing for earlier intervention. They're important for people who smoke, have diabetes, hypertension, heart disease, obesity, or a family history of kidney disease, as these conditions increase kidney disease risk.
Creatinine with eGFR also guides medication dosing, as many drugs are cleared by the kidneys and may require adjustment when kidney function is compromised. These markers also help assess the progression of known kidney disease and monitor the effectiveness of treatments.
Associated Symptoms
Creatinine with eGFR is a laboratory finding rather than a medical condition itself. However, conditions associated with high creatinine/low eGFR levels, potentially indicating reduced kidney function, may present with the following symptoms:
- Changes in urination (foamy/bubbly urine, decreased output)
- Metallic taste in mouth (potentially caused by a buildup of urea, creatinine, and other nitrogen-containing compounds in your blood)
Clinical Ranges
Lab Reference Range: ≥90 mL/min/1.73 m²
Lifestyle Factors That Can Impact It
Activities that can impact creatinine with eGFR levels include:
- Physical activity: Regular exercise builds muscle mass, which can increase baseline creatinine levels slightly. This isn't harmful, but reflects increased muscle metabolism.
- Protein intake: High-protein diets, especially those containing meat, can temporarily raise creatinine levels. This may be more significant in people with compromised kidney function.
- Hydration: Dehydration concentrates creatinine in the blood, leading to elevated readings.
- Smoking: Tobacco use damages blood vessels, including those in the kidneys, potentially leading to reduced kidney function and elevated creatinine over time.
- Weight management: Obesity contributes to diabetes and hypertension, both major risk factors for kidney disease.
Other Factors That Can Impact It
Genetic Conditions
- Polycystic Kidney Disease (PKD): This inherited disorder causes fluid-filled cysts to develop in the kidneys, gradually replacing normal kidney tissue and reducing function.
- Alport Syndrome: This genetic condition affects kidney structure, leading to progressive kidney damage.
Medical Conditions
- Diabetes: Chronic high blood sugar damages the kidneys' filtering units, reducing their ability to remove creatinine from the blood.
- Hypertension: High blood pressure damages blood vessels, including those in the kidneys, reducing their filtering ability.
- Glomerulonephritis: Damage to the kidney's filtering units affects their function.
- Heart failure: Decreased cardiac output reduces blood flow to the kidneys, impairing their filtering function.
- Urinary tract obstruction: Blockages in urine flow (from stones, enlarged prostate, etc.) can cause pressure on the kidneys, damaging tissue and reducing filtering function.
Medications and Supplements
- Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen
- ACE inhibitors and angiotensin receptor blockers (ARBs)
- Certain antibiotics (aminoglycosides, vancomycin)
- Some chemotherapy drugs
- Contrast dyes used in imaging tests
- Certain supplements (creatine)
Individual Factors
- Age: Kidney function naturally declines with age.
- Sex: Men typically have higher creatinine levels than women due to greater muscle mass.
- Race/genetic ancestry: African American individuals may have higher creatinine levels, though many labs now use race-free eGFR equations.
- Pregnancy: Normal pregnancy causes increased kidney filtration, potentially increasing eGFR and lowering creatinine levels. Conversely, conditions like preeclampsia can impair kidney function and raise creatinine.
- Body size: Individuals with more muscle mass typically produce more creatinine.
Testing Accuracy and Stability
Creatinine and eGFR tests are generally reliable, but several factors can affect their accuracy.
Factors That Can Affect the Accuracy of Your Test
- Recent meat consumption can temporarily raise creatinine levels
- Recent exercise
- Dehydration or overhydration
- Pregnancy
- Very low or high body weight
- Certain medications can interfere with lab measurements
- Significant liver disease (affects creatinine metabolism)
How It Relates to Other Markers
Other markers can provide insights about health status when viewed alongside creatinine with eGRF results. These tests may include:
- Blood Urea Nitrogen (BUN): Measures another kidney waste product. Together with creatinine, the BUN-to-creatinine ratio helps distinguish between acute and chronic kidney problems and can indicate dehydration or cardiac issues.
- Cystatin C: An alternative filtration marker not affected by muscle mass, providing additional information about kidney function.
- Urine Albumin-to-Creatinine Ratio (uACR): Detects small amounts of protein in urine, may be the earliest sign of kidney damage, particularly in diabetic kidney disease.
- Electrolytes (Sodium, Potassium, Calcium, Phosphate): Kidneys regulate these minerals; imbalances can indicate kidney dysfunction severity.
- Complete Blood Count (CBC): Can detect anemia, which may be caused by chronic kidney disease.
What Results May Mean in the Context of Other Markers
- High Creatinine + High BUN + Low eGFR: May indicate significant kidney disease.
- High Creatinine + High Urine Albumin: Could indicate both functional impairment and structural damage to the kidneys' filtering structures.
- Declining eGFR + Rising Potassium, Phosphorus, + Declining Calcium: May suggest advanced kidney disease with bone and mineral metabolism issues.
- Rising Creatinine + Declining Hemoglobin: May indicate chronic kidney disease progressing to impaired erythropoietin production and anemia.
Follow-up Considerations
If your creatinine with eGFR is abnormal, your provider may make some of the following recommendations. You should always speak to your doctor if you have medical questions or before making medical decisions.
When Re-Testing May Be Appropriate
- Normal results with no risk factors: Annually during routine check-ups
- Borderline results (eGFR 60-89): Every 6-12 months
- Mild kidney dysfunction (eGFR 45-59): Every 3-6 months
- Moderate dysfunction (eGFR 30-44): Every 2-3 months
- Severe dysfunction (eGFR < 30): Monthly or as directed by a nephrologist
- After starting new medications that affect kidney function: 1-2 weeks after initiation
Additional Testing Your Doctor May Consider
- 24-hour urine collection: Provides more accurate measurement of kidney function and protein excretion.
- Kidney ultrasound: Evaluates kidney size, structure, and potential obstructions.
- Cystatin C and combined eGFR equations: Improves accuracy of kidney function assessment.
- Comprehensive metabolic panel: Assesses electrolyte balance and acid-base status.
When Additional Care May Be Warranted
- Rapid decline or very low eGFR
- Significant protein in urine
- Symptoms of uremia (severe fatigue, nausea, confusion, itching)
- Difficult-to-control hypertension with kidney dysfunction
- Significant electrolyte abnormalities
Bibliography
References
1. Levey, Andrew S., et al. "A New Equation to Estimate Glomerular Filtration Rate." Annals of Internal Medicine, vol. 150, no. 9, 2009, pp. 604--612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006.
2. Inker, Lesley A., et al. "KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD." American Journal of Kidney Diseases, vol. 63, no. 5, 2014, pp. 713--735. https://doi.org/10.1053/j.ajkd.2014.01.416.
3. Webster, Angela C., et al. "Chronic Kidney Disease." The Lancet, vol. 389, no. 10075, 2017, pp. 1238--1252. https://doi.org/10.1016/S0140-6736(16)32064-5.
4. Ferguson, Tyrone W., Paul Komenda, and Navdeep Tangri. "Cystatin C as a Biomarker for Estimating Glomerular Filtration Rate." Current Opinion in Nephrology and Hypertension, vol. 24, no. 3, 2015, pp. 295--300. https://doi.org/10.1097/MNH.0000000000000115.
5. National Kidney Foundation. "K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification." American Journal of Kidney Diseases, vol. 39, no. 2 Suppl 1, 2002, pp. S1--S266.
6. Parikh, Chirag R., and Sherry G. Mansour. "Perspective on Clinical Application of Biomarkers in AKI." Journal of the American Society of Nephrology, vol. 28, no. 6, 2017, pp. 1677--1685. https://doi.org/10.1681/ASN.2016101127.
7. Stefani M., Singer R.F., Roberts D.M. "How to Adjust Drug Doses in Chronic Kidney Disease." Australian Prescriber, vol. 42, no. 5, 2019, pp. 163--167. https://doi.org/10.18773/austprescr.2019.054.
8. Baxmann, A.C., et al. "Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin C." Clinical Journal of the American Society of Nephrology, vol. 3, no. 2, 2008, pp. 348--354. https://doi.org/10.2215/CJN.02870707.
9. Juraschek, S.P., et al. "Effect of a High-Protein Diet on Kidney Function in Healthy Adults: Results from the OmniHeart Trial." American Journal of Kidney Diseases, vol. 61, no. 4, 2013, pp. 547--554. https://doi.org/10.1053/j.ajkd.2012.10.017.
10. Halimi, J.M., et al. "Effects of Current Smoking and Smoking Discontinuation on Renal Function and Proteinuria in the General Population." Kidney International, vol. 58, no. 3, 2000, pp. 1285--1292. https://doi.org/10.1046/j.1523-1755.2000.00284.x.
11. Orth, S.R. "Cigarette Smoking: An Important Renal Risk Factor---Far Beyond Carcinogenesis." Tobacco Induced Diseases, vol. 1, no. 2, 2002, pp. 137--155. https://doi.org/10.1186/1617-9625-1-2-137.
12. Chang, A.R., Zafar W., and Grams M.E. "Kidney Function in Obesity---Challenges in Indexing and Estimation." Advances in Chronic Kidney Disease, vol. 25, no. 1, 2018, pp. 31--40. https://doi.org/10.1053/j.ackd.2017.10.007.
13. Chen, X., et al. "Serum Creatinine Levels, Traditional Cardiovascular Risk Factors and 10-Year Cardiovascular Risk in Chinese Patients with Hypertension." Frontiers in Endocrinology, vol. 14, 2023. https://doi.org/10.3389/fendo.2023.1140093.
14. Wei, L., et al. "Estimated GFR Reporting Is Associated with Decreased Nonsteroidal Anti-inflammatory Drug Prescribing and Increased Renal Function." Kidney International, vol. 84, no. 1, 2013, pp. 174--178. https://doi.org/10.1038/ki.2013.76.
15. Oliveira, J.F., et al. "Prevalence and Risk Factors for Aminoglycoside Nephrotoxicity in Intensive Care Units." Antimicrobial Agents and Chemotherapy, vol. 53, no. 7, 2009, pp. 2887--2891. https://doi.org/10.1128/AAC.01430-08.
16. Modi, K., Padala S.A., Gupta M. "Contrast-Induced Nephropathy." StatPearls [Internet], StatPearls Publishing, 2025. https://www.ncbi.nlm.nih.gov/books/NBK448066/.
17. van Buren, M.C., et al. "Effect of Pregnancy on eGFR After Kidney Transplantation: A National Cohort Study." Transplantation, vol. 106, no. 6, 2022, pp. 1262--1270. https://doi.org/10.1097/TP.0000000000003932.
18. Zhu, C., et al. "Predicting Mortality in Heart Failure: BUN/Creatinine Ratio in MIMIC-III." Frontiers in Cardiovascular Medicine, vol. 12, 2025. https://doi.org/10.3389/fcvm.2025.1510317.




